Skip to main content

Current Research on Epilepsi Disease As Sunovion Epilepsy, Anticonvulsant Drugs And New Epilepsy Drugs


Epilepsy  Synopsis

Epilepsy is a major neurological disorder in which the brain activity becomes abnormal causing periods of unusual behavior and sensations. It is also known as vanquix in Many regions. The disorder is noticeable in young children and young adults. Moreover, brain injuries which can trigger post-traumatic epilepsy (PTE) and post-traumatic seizure (PTS) can fuel the demand in the epilepsy market.

what is epilepsi disease and anticonvulsant drugs in 2019? 

The Global Epilepsy Market is projected to touch a valuation of USD 9,509.2 million by 2023, exhibiting a CAGR of 8.20% over the forecast period (2018-2023). High prevalence of anti epilepsy drugs among the geriatric population and increase in cases of brain injuries caused by accidents are major factors driving market growth of epilepsy medication.
Free Sample Here Developing economies in Africa offer a prime opportunity for investment in the market. According to a report by the World Health Organization (WHO) in 2017, nearly 80% of the patient population with epilepsy live in middle- and low-income countries. Manufacturers of epileptic drugs can capitalize on the opportunity to invest and establish facilities to cater to the growing demand.
The high susceptibility rate of attaining epilepsy pills among the elderly of levetiracetam drug class is projected to drive market demand. As per the 2018 study in the Neuroepidemiology Journal, the prevalence rate of drugs for epilepsy among individuals older than 60 was 7.7 per 1000. 

Key players in the epilepsy market include,

·         Eisai Co. Ltd. (Japan)
·         Novartis AG (Switzerland)
·         Pfizer Inc. (US)
·         GW Pharmaceuticals PLC (UK)
·         Abbott Laboratories (US)
·         UCB SA (Belgium)
·         LivaNova PLC (UK)
·         Medtronic PLC (Ireland)
·         Johnson & Johnson Services Inc. (US)
·         GlaxoSmithKline PLC (UK)
·         and NeuroPace Inc. (US).

Comments

  1. this Research is also have Great Details of Other Content of https://healthcareresearchmarket09.blogspot.com/2019/10/epilepsy-market-making-money-moving.html

    ReplyDelete

Post a Comment

Popular posts from this blog

Global Cowden Syndrome Market Technologies, Clinical Review and Industry Outlook To 2023

  Global Cowden Syndrome Market  Research Report: By Site (Breast, Thyroid, Colorectal, Kidney, Skin), Treatment (Genetic Testing, Chemotherapy, Targeted Therapy, Surgery & Radiation Therapy, Hormone Therapy), End User (Hospital & Clinics) - Forecast till 2023 Market Highlights Cowden syndrome is part of the PTEN hamartoma tumor syndrome. Cowden syndrome is characterized by a high risk of both benign and cancerous tumors of the breast, thyroid, endometrium, colorectal, kidney, and skin. The global Cowden syndrome market is expecting a healthy growth in the coming future. The global market is majorly driven by increasing Cowden syndrome patients across the globe. Additionally, increasing smoking population and rising consumption of alcohol have spurred the growth of the market. However, long time for approval and side effects of the treatment may hinder the growth of the market. Intended Audience Pharmaceutical Companies Government and private research companies Researc...

H. Pylori (Helicobacter Pylori) Test Market Top Company Profiles, Latest Technology, Global Size and Industry Trends

  H. Pylori (Helicobacter Pylori) Test Market Size, Revenue, Global Opportunity and Value Chain 2019 to 2023 H. Pylori (Helicobacter Pylori) Test Market Research Pune, India, October 2019/MRFR Press Release/- Market Research Future has published its Half-Cooked Research Report on the Global H. Pylori (Helicobacter Pylori) Test Market. The  H. Pylori (Helicobacter Pylori) Test Market size  analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. Global H. Pylori (Helicobacter Pylori) Test Market, by Region North America US Canada Europe Spain Germany Italy France UK Rest of Europe Asia-Pacific Australia China Japan South Korea India Rest of Asia-Pacific Middle East & Africa UAE Saudi Arabia Egypt Rest of Middle East and Africa The report also appraises the supervisory scenarios which affect various decisions in the market. With a...

Insulating Paints And Coatings Market 2021 Share Acquire Huge Growth, Global Opportunities and Trends to 2026

  Exactitude Consultancy 2021 Press Release: Global Insulating Paints and Coatings Market Hygiene which is one of the important factors for the well-being of person has never been highlighted as it is spread in the era after the onset of Covid-19. Hand hygiene and hygiene of frequently touched surfaces has become of paramount importance. Household and commercial spaces have increasingly invested in the products which enhances the hygiene quality of the ecosystem. Apart from increasing the surface’s durability, appearance, corrosion resistance, etc., these coatings also protect from harmful disease-causing microbes. There is increasing need to protect surfaces, equipment, walls, textiles, food and other susceptible things from microbes which eventually finds the way to the humans. It is impossible to disinfect every time the object and use strong chemicals frequently. This requirement can be completed by Paints and Coatings market. The industrial paint segment, on the other hand, in...